EUGCX | VEURX | EUGCX / VEURX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 27 years | 34 years | - |
Gain YTD | 8.080 | 0.198 | 4,074% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 117M | 24.5B | 0% |
Annual Yield % from dividends | 0.00 | 3.11 | - |
Returns for 1 year | 15.14 | 6.11 | 248% |
Returns for 3 years | -33.51 | -4.30 | 780% |
Returns for 5 years | 15.46 | 16.42 | 94% |
Returns for 10 years | 22.41 | 21.29 | 105% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 27.78 | 0.40 | +1.47% |
First Trust Nasdaq Pharmaceuticals ETF | |||
VFMO | 174.69 | 2.23 | +1.29% |
Vanguard US Momentum Factor ETF | |||
FLV | 70.70 | 0.54 | +0.77% |
American Century Foc Lrg Cp Val ETF | |||
BLCN | 28.66 | 0.16 | +0.56% |
Siren Nasdaq NexGen Economy ETF | |||
SPIB | 32.93 | -0.02 | -0.06% |
SPDR® Portfolio Interm Term Corp Bd ETF |